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Effects of intravenous diclofenac on postoperative sore throat in
patients undergoing laparoscopic surgery at Aga Khan University
Hospital, Nairobi: A prospective, randomized, double blind
controlled trial
Thang’a P, Kamya D, *Mung’ayi V
Department of Anaesthesia, Agakhan University, East Africa

Abstract
Background: postoperative sore throat is the commonest complication after endotracheal intubation. The efficacy of
intravenous non-steroidal anti-inflammatory drugs in alleviating postoperative sore throat has not been investigated.
Objective: To evaluate the effect of intravenous diclofenac sodium on the occurrence and severity of postoperative sore
throat.
Methods: 42 in-patients scheduled for laparoscopic surgery were randomized into two equal groups to receive either a single
dose of 75mg intravenous diclofenac sodium in addition to standard treatment taken at our hospital for the prevention of
postoperative sore throat or to receive standard treatment only. All patients were interviewed postoperatively at 2, 6 and 18
hours. Data of the baseline characteristics, the incidence and severity of sore throat were collected. If sore throat was present,
a Visual Analogue Score was used to assess its severity.
Results: the baseline characteristics of the participants were similar. The majority of the patients undergoing laparoscopic
surgery were women. There was no statistically significant difference in the occurrence or severity of postoperative sore
throat between the diclofenac and standard treatment groups at 2, 6 and 18 hours postoperatively.
Conclusion: Intravenous diclofenac sodium does not reduce the occurrence or severity of postoperative sore throat.
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Introduction
Sore throat is a common, uncomfortable, distressing
sequel of tracheal intubation that contributes to
postoperative morbidity and patient dissatisfaction16
. The incidence of postoperative sore throat (POST)
after tracheal intubation varies from 6.6 to 90%7-12.
The pathogenesis of POST is attributed to
traumatisation, local irritation and inflammation of
the airway mucosa during tracheal intubation13-15.
Numerous non-pharmacological and
pharmacological measures aimed at attenuating
POST have been investigated with varying success.
Among the non-pharmacological methods, a smaller
sized endotracheal tube (ETT), lubricating the ETT
with water soluble jelly, careful airway
instrumentation, intubation after full relaxation, gentle
oropharyngeal suctioning, minimizing intracuff
pressure, and extubation when the tracheal tube cuff
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is fully deflated have been reported to decrease the
incidence of POST12, 13, 16, 17.
Various pharmacological measures, including
lignocaine, steroids, non-steroidal anti-inflammatory
drugs, gargling with azulene sulfonate, have been
reported to decrease the incidence of POST 1, 2, 9, 18,
19, 39, 40
.
Despite the inflammatory pathogenesis of
POST, the evidence supporting the use of nonsteroidal anti-inflammatory drugs (NSAIDs) for
POST is limited5, 8, 10. Topical diclofenac epolamine,
a NSAID, has been shown to be effective in reducing
the severity and incidence of POST10. However, the
more readily available diclofenac sodium which has
been found to be effective in the treatment of
postoperative pain when used orally, rectally or
intravenously20-22 has not been evaluated for its effect
on POST.
This study aimed to investigate the effect
of intravenously administered diclofenac sodium on
the occurrence and severity of POST.
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Methods
Written approval to conduct the study was sought and
obtained from the Aga Khan University Research
Ethics Committee (REC). Recruitment into this study
was wholly voluntary and a participant could withdraw
their consent at any time without any consequence to
their routine care. Eligible patients were approached
and received a consent-seeking information sheet. The
investigator was also available to answer any further
enquiries that arose. After full disclosure, eligible
patients who agreed to participate in the study signed
an informed consent form.
This is a prospective, randomized, controlled double
blinded trial.
The study was conducted at Aga Khan
University Hospital, Nairobi (AKUH, N). The AKUH,
N is a 254-bed private not-for-profit institution that
provides tertiary and secondary level health care
services.
The study population consisted of all adult
inpatients endotracheally intubated for laparoscopic
surgery at the AKUH, N. This patient population was
selected for this study because postoperative pain for
both gynaecological and general surgery laparoscopic
procedures is well controlled with pre-emptive
infiltration of the surgical incision sites with local
anaesthetic23-33, and with a combination of an opioid
and paracetamol postoperatively 25, 34, 35. This reduced
the need for a NSAID postoperatively the
administration of which would have confounded the
results of this study.
All adult American Society of
Anaesthesiologists (ASA) class 1-3 inpatients that would
be intubated for laparoscopic surgery and had no
contraindication to use of intravenous diclofenac were
included. A sample size of 36 patients was sufficient
to demonstrate a 49% difference in the occurrence
of POST between patients who receive standard
treatment at AKUH, N and those who received
intravenous diclofenac. The study was powered at 90%
with an alpha of 5%. Previous studies showed 13.6%
occurrence of POST when topical diclofenac was
used10. There are no studies that look specifically at
the composite effect of the standard treatment
measures used at AKUH, N to prevent the occurrence
of POST. Thus, for the calculation of sample size, a
63% occurrence of POST at AKUH, N was
hypothesized from the study done by Edomwonyi et
al7. Edomwonyi’s study was chosen because it looked
at the incidence of POST using standard treatment
measures taken at Benin Teaching Hospital, it is the
only published study done on the incidence of POST
in Africa and the incidence of POST lies within the
international 6.6-90% incidence of POST.
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The sample size was increased by 15% to
allow for drop out bringing the sample size to 42
patients, 21 patients in each arm. Simple randomisation
was used in this study. Using a computer program, the
statistician randomly assigned either drug or standard
treatment to a list of 42 patients. This randomisation
code handed over to a designated pharmacist.
Thirty minutes before the recruited patient’s scheduled
surgery, the investigator gave the designated pharmacist
the study patient’s unique hospital file number. Using
the randomization code, the pharmacist then prepared
the corresponding 200ml saline bag with or without
diclofenac and labelled it with the patient’s file number.
The investigator collected the bag and delivered it to
the anaesthetist assigned to the case. The intravenous
diclofenac sodium available at AKUH, N comes as a
3ml colourless solution. To prevent precipitation when
the diclofenac was added to normal saline, 0.5ml of
8.4% sodium bicarbonate-also a colourless liquid- was
added to the mixture. Thus, the saline bags with
diclofenac and those without contained colourless fluid
indistinguishable from each other.
At the beginning of the study all consultant
anaesthetists, anaesthesia resident doctors, anaesthetic
assistants and nurses were familiarized with the scope
of the study and tools of data collection and their
cooperation sought. The 200ml saline infusion with
or without diclofenac sodium was started just before
induction of anaesthesia and run over 30min. Patient
anaesthesia was induced and maintained with the
anaesthetist’s choice of drugs.
Female patients were intubated with size
7.0mm ±0.5 internal diameter tubes and male patients
with 7.5mm ±0.5 internal diameter tubes lubricated
with water soluble 2% lignocaine gel. A Smiths Medical
Portex® cuff manometer was used to measure cuff
pressures and whenever necessary to deflate the cuffs
to a pressure of d”20mmHg11, 17. Cuff pressures were
measured every 30min and adjusted accordingly 8.
Intraoperative pain management consisted of 0.5%
bupivacaine infiltrated pre-emptively into the port sites
at a dose of 1-2mg/kg28, 36-38, Intramuscular morphine
10mg or Pethidine 75mg according to the
anaesthetist’s preference and intravenous paracetamol
1g.
Postoperative pain management for the first
24hrs consisted of intravenous paracetamol 1g 6hourly
and Intramuscular morphine 10mg 4-6hourly or
intramuscular Pethidine 75mg 6hourly.
Patients in either arm who developed POST would
be treated according to severity of sore throat.
Those with mild POST would be treated with throat
lozenges every 2-3 hours41.
Those with moderate to severe POST would be treated
with ketamine 40mg in 30ml saline gargle23.
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If patients had surgical site pain despite
prescribed analgesics they would have oral, rectal or
intramuscular diclofenac sodium added to their
postoperative analgesia and be dropped out of the
study. None of the patients required rescue diclofenac
during the study period, thus none were dropped out.
Intraoperative data were collected by trained
anaesthetic assistants using a data collection form.
Data on the presence or absence of POST
and its severity were collected by the principal
investigator using a structured questionnaire at 2, 6
and 18 hours postoperatively. Severity of POST was
graded using a visual analogue scale, (VAS). The VAS
has been found to have both validity and
reproducibility for the measurement of postoperative
pain and acute pain42-45. This questionnaire was pretested on 20 regular postoperative inpatients that had
been intubated for surgery. No revisions were
necessary.
All verified raw data were coded and entered into the
Statistical Package for Social Sciences (SPSS) program,
version 11.5 ( SPSS Inc. Chicago, IL, USA). Data
analysis was performed using the same software.
Categorical data was summarised using a table
and proportions were indicated. All count variables

were summarised using median and continuous
variables summarised using mean.
Difference in the occurrence of POST were analysed
using Fischer’s exact test and Pearson Chi square test.
Severity of POST was analysed using the Mann –
Whitney U – test.
A p value of <0.05 was considered statistically
significant.
Results
Data collection was carried out over three and a half
months-between January 2011 and April 2011. A total
of 42 participants were recruited, almost entirely from
the surgical wards, and randomised for the study. Two
participants, one allocated to diclofenac and the other
to standard treatment arm, were dropped out of the
study after randomisation and were excluded from
analysis. The former was admitted to the intensive
care unit for ventilation, and the latter’s surgery was
converted from a laparoscopy to a laparotomy.
Consequently, forty participants were included in the
data analysis, twenty in each arm.
Baseline characteristics of patients in the two arms
of the study were similar (table 1).

Table 1: Patient characteristics
Diclofenac n=20
Standard treatment n=20
Age(years)
37.5 ± 9.2
36.5 ± 5.9
ASA
1 (1,2)
1 (1,2)
Gender
Male
3 (75)
1 (25)
Female
17 (47.2)
19 (52.8)
Surgical procedure
Elective surgery
20 (51.3)
19 (48.7)
Emergency surgery
0
1 (100)
Tube size
6.5
3 (50)
3 (50)
7.0
14 (46.7)
16 (53.3)
7.5
3 (75)
1 (25)
Anaesthetists level of experience
PGY1
1 (33.3)
2 (66.7)
PGY 2
2 (33.3)
4 (66.7)
PGY4
7 (58.3)
5 (41.7)
Registrar
1 (100)
0
Consultant
9 (50)
9 (50)
Number of intubation attempts
1
16 (50)
16 (50)
2
2 (50)
2 (50)
3
2 (50)
2 (50)
Cricoid pressure given
12 (52.2)
11 (47.8)
Use of nitrous oxide
10 (50)
10 (50)
Pharyngeal trauma
1 (16.7)
5 (83.3)
Duration of surgery(min)
114 ± 51.2
129 ± 66
NG tube inserted
3 (30)
7 (70)
Note: Mean age and duration of surgery are presented as mean ± SD; ASA is presented as median (min, max); All other
variables are presented as n(%) PGY- postgraduate year of training NG-nasogastric tube
African Health Sciences Vol 13 Issue 4 December 2013
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There was less POST in the diclofenac group
compared to the standard treatment group at 2 and
6 hours but this did not reach statistical significance.

At 18 hours, the occurrence of POST was similar in
the two groups
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No of patients with sore throat

9
8
7
6
5
4
3
2
1
0
2hrs

Diclofenac

6hrs
Standard treatment2

18hrs

Figure 1: Occurrence of POST

42 Patients assessed
for Eligibility

42 Randomized

21 patients in
standard treatment
group

21 patients in IV
diclofenac group

1 patient Lost to
up follow up (ICU
admission)

1 patient lost to
follow up
(conversion to
laparotomy)
40 Analyzed

Figure 2. Flow diagram of patient distribution
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The difference in the median VAS score between
the diclofenac and standard treatment groups at 2,
6, and 18hrs was not statistically significant as shown
table 2.
At all study time points patients were asked
whether their throats felt normal and if they did
not, the patient was asked to describe the pharyngeal
discomfort in their own words. Taking the total

sample size as the denominator, the proportion of
patients who experienced some degree of
discomfort was 92%, 65% and 37.5% at 2, 6 and 18
hours respectively. Frequency of the main terms used
to describe the pharyngeal discomfort is shown in
table 3. in order of increasing severity from dry to
no voice.

Table 2: Severity of POST
Diclofenac

Standard
treatment
VAS score at 2 hours
0(0,5)
0(0,5)
VAS score at 6 hours
0(0,6)
0(0,4)
VAS score at 18 hours
0(0,4)
0(0,3)
Note: VAS is presented as median (min, max)

p value
0.361
0.678
0.862

Table 3: Patient’s description of pharyngeal discomfort

Dry
Very Dry
Irritated/scratchy
Something stuck/blocked
No voice

No. of patients
at 2 hours
20
4
6
5
5

No. of patients
at 6 hours
15
1
3
3
0

No. of patients
at 18 hours
5
0
2
0
1

Discussion
The pathogenesis of POST is attributed to trauma,
local irritation and inflammation of the airway
mucosa during tracheal intubation 13-15. This tissue
damage results in the release of prostaglandins which
cause inflammation and pain 20,40,41. Diclofenac
sodium is a potent inhibitor of prostaglandin
biosynthesis accounting for its pronounced antiinflammatory and analgesic properties 41-43. This study
was undertaken to investigate if this antiinflammatory and analgesic effect of diclofenac
sodium would reduce the occurrence and severity
of POST.
The major finding of this study is that a
single 75mg dose of intravenous diclofenac sodium
infused over 30 minutes at the induction of
anaesthesia does not produce a statistically significant
reduction in the occurrence or severity of POST.
However, at 2 and 6 hours postoperatively, fewer
patients in the diclofenac group had POST compared
to the standard treatment group even if this
difference was not statistically significant. By 18hrs
the occurrence of POST was equal in both groups.
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The reduced occurrence of POST at 2 and 6 hours
may be explained by the pharmacokinetics of
intravenous diclofenac. Once administered
intravenously, diclofenac reaches its peak plasma
concentration rapidly. The plasma concentration falls
to half the peak value in 1.1 to 2hrs 44,45. Thus, the
peak effect of intravenous diclofenac is in the first
2hours after administration. From 5.5hrs after
administration plasma concentration of diclofenac
is below detection levels 45 hence the reduction in
activity.
A subjective assessment by the patient of
how their throats felt postoperatively was sought. It
was very interesting to note that at 2 hours 92% of
patients had some degree of discomfort with or
without a sore throat. This goes to show that, in the
immediate postoperative period, some degree of
throat discomfort will occur in almost all patients.
This result has a number of implications on the
anaesthesia process. First, the possibility of
developing throat discomfort should be
incorporated in the preoperative counselling of
1003

patients. Forewarning the patient would help reduce
the number of factors causing patients’ anxiety in
the already stressful perioperative period. Second,
this outcome emphasises the need to take all available
pharmacological and non-pharmacological measures
to reduce the risk of developing throat pain and
discomfort post tracheal intubation. Third, the
anaesthetist should ask the patient if they have throat
pain or discomfort postoperatively and take the
necessary measures to alleviate it.
There are only three prior studies
investigating the use of NSAIDS to reduce the
incidence and severity of POST. 5,8,10 This study
differs from these in two main ways. Firstly this study
is the first to investigate the effect of an intravenous
NSAID on POST. In all previous studies a topical
preparation was administered. Secondly, none of
the prior studies investigated diclofenac sodium.
In all previous studies, the local application
of NSAIDs resulted in a statistically significant
reduction in the incidence and/or severity of POST.
Rahimi et al used a diclofenac epolamine patch
applied to the anterior aspect of the neck, Ozaki et
al, a ketoprofen patch also applied to the throat 8
and Agarwal et al aspirin and benzydamine
hydrochloride gargles 5. The results from these studies
imply that the anti-inflammatory action of NSAIDS
is most effective with local application of NSAIDS
The topical application of the NSAIDS in close
proximity to the site of action or at the site of action
may result in high drug concentrations in the
pharyngeal mucosa. When diclofenac is administered
intravenously, the bioavailability of the drug is 100%.
However, the concentration of drug achieved in the
pharyngeal mucosa after intravenous administration
has not been investigated. Thus, a difference in drug
concentration at the pharyngeal mucosa may account
for the topical agents producing decrease in the
incidence and severity of POST. It would be
interesting to conduct a study comparing the effect
of a diclofenac sodium patch and other topical
NSAID preparations on POST.
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